General Information
Revision date
2019-01-16
Product name
Verapamil Hydrochloride Injection USP , 2.5 MG/ML (2 mL, 4 mL)
CAS No.
152-11-4
Emergency telephone
91 2714 671600
Icons in SDS
Company Information
company name
Amneal Pharmaceuticals Pvt. Ltd.
Section 2
Other physicochemical hazards
Thermal Decomposition can generate NOx, COx, etc.
Hazard statements
May cause skin irritation
Potential Acute Health Effects
Hazardous in case of ingestion. Hazardous in case of skin contact (irritant, permeator), of eye contact (irritant). Slightly hazardous in case of inhalation. Known clinical effects: May cause low blood pressure and dizziness. Occasional, transient changes reported in liver function tests, but no liver damage seen. This material has been shown to be secreted in low concentrations in human breast milk. CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available.
Teratogenic Effects
Not available DEVELOPMENTAL TOXICITY: Not available. The substance is toxic to lungs, mucous membranes. Repeated or prolonged exposure to the substance can produce target organs damage. Note: This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.